TBP-TA 具有强大的抗菌活性,可以对抗抗康素耐药性肠球菌
Mengying Zhang1, Shijie Zhou1, Yifan Liu1
1Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University, Hefei 230036, China.
Bioorganic chemistry
|January 17, 2026
概括
一种新的小分子化合物,TBP-TA,有效地对抗牲畜中抗旺素耐药性肠球菌 (VRE) 感染. 与动物模型中的linezolid相比,TBP-TA在减少细菌负载和改善肠道健康方面表现出卓越的疗效.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 兽医医学 兽医医学 兽医医学
背景情况:
- 抗菌素耐药性 (AMR) 对牲畜健康和生产力构成重大威胁.
- 小分子化合物为抗击细菌感染提供了多种机制.
研究的目的:
- 评估小分子化合物TBP-TA对抗万科米辛耐药性肠球菌 (VRE) 的抗菌疗效.
- 在牲畜模型中研究TBP-TA的作用机制和治疗潜力.
主要方法:
- 使用了体外抗菌试验和体外动物模型.
- 机械学研究包括膜完整性,质子动力,排气功能和反应性氧物种分析.
- 进行了非向的代谢学和组织病理学分析.
主要成果:
- TBP-TA通过破坏膜完整性,分散质子动力,并诱导活性氧物种,对VRE表现出强大的杀菌活性.
- 代谢分析显示,TBP-TA会扰乱能量代谢和抗氧化防御系统.
- 在小鼠模型中,TBP-TA显著减少了VRE殖民,并缓解了肠道损伤,超过了linezolid.
结论:
- 通过多种机制,TBP-TA对VRE表现出强烈的杀菌作用.
- TBP-TA显示出作为治疗动物多药耐药细菌感染的治疗剂的前景.
相关概念视频
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Antimicrobial Effectiveness
913
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
913
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Antibiotic Selection
59.4K
Overview
59.4K


